As of the most recent data (March 2026), HQL shows a common stock of $300K. That compares with $290K in the prior-year period — up 5.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQL's common stock is now $300K (was $290K) — a 5.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Life Sciences Investors is outperforming or lagging.

Tracking HQL's common stock over time shows whether abrdn Life Sciences Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $300K That compares with $290K in the prior-year period — up 5.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has abrdn Life Sciences Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $300K) with ownership activity and broader fundamentals.